Celgene Corp (NASDAQ:CELG)

114.44
Delayed Data
As of May 29
 -0.49 / -0.43%
Today’s Change
75.62
Today|||52-Week Range
129.06
+2.31%
Year-to-Date

Today’s Trading

Previous close114.93
Today’s open114.87
Day’s range114.00 - 116.00
Volume4,350,904
Average volume (3 months)5,287,874
Market cap$90.8B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+28.13%
Earnings growth (next 5 years)+23.60%
Revenue growth (last year)+17.89%
P/E ratio39.1
Price/Sales11.75
Price/Book14.03

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-1.35-1.96%
LLYEli Lilly and Co+2.49+3.26%
VRXValeant Pharmaceutic...-2.96-1.22%
ABBVAbbVie-0.88-1.30%
Data as of 4:07pm ET, 05/29/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.14
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers